Market Definition

3D Bioprinting is a type of additive manufacturing that uses 3D printing to create biomedical parts that are as close to natural tissue properties as possible. The layer-by-layer process is most widely employed in 3D Bioprinting to deposit ingredients called bioinks to build tissue-like structures that are later used in medical and tissue engineering applications. The 3D Bioprinting method is divided into three stages: pre-bioprinting, bioprinting, and post-bioprinting.

3D bioprinting is commonly utilised to create organ and tissue constructions that can be used in drug research, scaffolding, and the development of medical implants. Furthermore, 3D Bioprinting is beginning to include the printing of scaffolds that can be utilised to rebuild joints and ligaments. 3D Bioprinting contributes to significant improvements in the medical field of tissue engineering by enabling research on novel materials known as biomaterials.

The market is divided into four segments based on technology: magnetic 3D bioprinting, laser-assisted bioprinting, inkjet 3D bioprinting, and microextrusion bioprinting. Among the total Inkjet market, one segment dominates the primary market since it allows for the printing of complicated living organs or tissues on culture substrates employing biomaterials. As a result, the widespread use of inkjet-based printing in the medical industry is contributing to the expansion of this market.

The 3D bioprinting market is predicted to develop significantly during the forecast period due to factors such as technological advancements for manufacturing customised items, an increase in the geriatric population, and a greater emphasis on R&D expenditure. Furthermore, the increased use of 3D printing in aesthetic operations, as well as inventions in 3D bioprinting, are likely to supplement the 3D bioprinting market expansion throughout the forecast period. Furthermore, the large disparity between the demand and availability of organ transplants indicates a significant need among patients and clinicians, and developing 3D bioprinting technologies have a high potential to bridge this gap. Although these factors contribute to the market's growth, a lack of experienced specialists to run technologically advanced 3D bioprinters can be a key impediment to the market's expansion. Conversely, increased stem cell research and increased awareness of 3D bioprinting are projected to provide lucrative prospects for 3D bioprinting market participants.

As the number of COVID-19 cases grows, there is a shortage of materials for both medical professionals and the general population. One of the most serious difficulties is the scarcity of COVID-19 test kits. As a result, many 3D bioprinting businesses are mass-producing 3D printers and related software.

Report Scope

The global market report scope consists of a comprehensive study covering primary factors impacting the industry trends. The study includes analysis of regional and country-level market dynamics. The scope also consists of competitive overview offering company market shares coupled with company profiles for key revenue contributing companies. The report scope covers a detailed competitive outlook covering market shares and profiles of key participants in the market share.

Major Market Players

This report offers the major market player’s profiles, such as Organovo Holdings, Inc. (US), CELLINK (Sweden), Allevi Inc. (US), Aspect Biosystems Ltd. (Canada), EnvisionTEC GmbH (Germany), Cyfuse Biomedical K.K. (Japan), Poietis (France), TeVido BioDevices (US), Nano3D Biosciences, Inc. (US), ROKIT Healthcare (South Korea), Digilab, Inc. (US), regenHU (Switzerland), GeSiM (Germany), Advanced Solutions Life Sciences (US), and Regenovo Biotechnology Co., Ltd. (China). 

The 3D Bioprinting Market report has been categorized as below

By Component

  • 3D Bioprinters

    • Microextrusion bioprinting

    • Inkjet 3D Bioprinting

    • Laser-assisted Bioprinting

    • Magnetic 3D Bioprinting

    • Other technologies *

  • Bioinks

    • Natural Bioinks

    • Hybrid Bioinks

    • Synthetic Bioinks

By Application

  • Research Applications

    • Drug Research

    • Regenerative Medicine

    • 3D Cell Culture

  • Clinical Application

    • Skin

    • Bone & Cartilage

    • Blood Vessels

    • Other Clinical Applications **

By Material

  • Living Cells

  • Hydrogels

  • Extracellular Matrices

  • Other Biomaterials***

By End User

  • Research Organization & Academic Institutes

  • Biopharmaceuticals Companies

  • Hospital

By Region

  • North America
  • Europe
  • Asia Pacific
  • Rest of World

The years considered for the study are as follows

  • Base year - 2020
  • Estimated year - 2021
  • Projected year – 2022
  • Forecast period - 2021 to 2027

Key Questions Addressed by the Report

  • New products/service competitors are exploring?
  • Key players in the 3D Bioprinting Market and how extreme is the competition?
  • What are the future market trends that manufacturers are emphasizing on in the future updates?
  • For each segment, what are the crucial opportunities in the market?
  • What are the key growth strategies embraced by key market players in the market?
  • What are the key success strategies adopted by major competitors in the market?

Why Buy this Report:

  • Obtain comprehensive insights on the 3D Bioprinting market trends
  • Note comprehensive analysis of the market status
  • Identifies the market opportunities and growth segments
  • Assessing business segments & product portfolios, and explain competitive dynamics
  • Provide strategy planning and industry dynamics to strengthen decision making

Report Content

1. Global 3D Bioprinting Market Introduction

1.1. Key Insights

1.2. Report Overview

1.3. Markets Covered

1.4. Stakeholders

2. Research Methodology

2.1. Research Scope

2.2. Market Research Process

2.3. Research Data Analysis

2.4. Market Size Estimation

3. Executive Summary

4. Market Overview

4.1. Introduction

4.2. Market Drivers and Restraints

5. By Component

    5.1.  3D Bioprinters

        5.1.1.  Microextrusion bioprinting

        5.1.2. Inkjet 3D Bioprinting

        5.1.3. Laser-assisted Bioprinting

        5.1.4. Magnetic 3D Bioprinting

        5.1.5. Other technologies *

    5.2. Bioinks

        5.2.1 Natural Bioinks

        5.2.2. Hybrid Bioinks

        5.2.3. Synthetic Bioinks

6. By Application

    6.1.  Research Applications

        6.1.1.  Drug Research

        6.1.2. Regenerative Medicine

        6.1.3. 3D Cell Culture

    6.2. Clinical Application

        6.2.1. Skin

        6.2.2. Bone & Cartilage

        6.2.3. Blood Vessels

        6.2.4. Other Clinical Applications **

7. By Material

7.1.  Living Cells

7.2.  Hydrogels

7.3. Extracellular Matrices

7.4. Other Biomaterials

8. By End User

8.1.  Research Organization & Academic Institutes

8.2.  Biopharmaceuticals Companies

8.3. Hospital

9. By Region

9.1. Key Points

9.2. North America

9.3. Europe

9.4. Asia Pacific

9.5. Rest of the World

10. Company Profile

(Profile contain company overview, products/services, financials & recent developments)

10.1. Organovo Holdings, Inc. (US), 

10.2. CELLINK (Sweden), 

10.3. Allevi Inc. (US), 

10.4. Aspect Biosystems Ltd. (Canada), 

10.5. EnvisionTEC GmbH (Germany), 

10.6. Cyfuse Biomedical K.K. (Japan), 

10.7. Poietis (France), 

10.8. TeVido BioDevices (US), 

10.9. Nano3D Biosciences, Inc. (US), 

10.10. ROKIT Healthcare (South Korea), 

10.11. Digilab, Inc. (US), 

10.12. regenHU (Switzerland), 

10.13. GeSiM (Germany), 

10.14. Advanced Solutions Life Sciences (US),

10.15.  Regenovo Biotechnology Co., Ltd. (China).

The 3D Bioprinting Market report has been categorized as below

By Component

  • 3D Bioprinters

    • Microextrusion bioprinting

    • Inkjet 3D Bioprinting

    • Laser-assisted Bioprinting

    • Magnetic 3D Bioprinting

    • Other technologies *

  • Bioinks

    • Natural Bioinks

    • Hybrid Bioinks

    • Synthetic Bioinks

By Application

  • Research Applications

    • Drug Research

    • Regenerative Medicine

    • 3D Cell Culture

  • Clinical Application

    • Skin

    • Bone & Cartilage

    • Blood Vessels

    • Other Clinical Applications **

By Material

  • Living Cells

  • Hydrogels

  • Extracellular Matrices

  • Other Biomaterials***

By End User

  • Research Organization & Academic Institutes

  • Biopharmaceuticals Companies

  • Hospital

By Region

  • North America
  • Europe
  • Asia Pacific
  • Rest of World

Licence Option

  • Single User 1500 USD
  • Multiple User 3500 USD

Quality assurance

A testimonial for service in the form of BBB “A” Accreditation.

Your personal and confidential information is safe and secure.

  - Information security

© 2021 Whipsmart. All Rights Reserved.

Terms of use| Site Map